Clinical Trials Browser

Phase 3 × Urothelial Cancer × Nivolumab × Clear all

NCT03036098 2026-03-06

CheckMate901

Phase 3 Active not recruiting

1,314 enrolled 23 charts 1 FDA

Urothelial Cancer